Sentence examples for outcome guidance from inspiring English sources

Novel antiviral medications and vaccines are currently in development to improve the clinical outcome of RSV infections; however, no COAs for RSV disease in infants that meet the requirements of the FDA patient-reported outcome guidance exist.

Novel antiviral medications are in development to improve the clinical outcomes of RSV; however, no clinical outcome assessments (COAs) for RSV have been developed in alignment with the United States Food and Drug Administration patient-reported outcome guidance to assist in the evaluation of new therapies.

In the future, it has to be clarified whether, in addition to clinical scores with unequivocal and clearly defined cut-offs, well defined immune parameters, such as distinct biomarker profiles, may improve diagnosis of infection and severity of disease, prediction of outcome, guidance and success of therapeutic interventions [ 3, 12, 13].

In the future, it has to be clarified whether, in addition to clinical scores, well defined immune parameters, such as distinct biomarker profiles, may improve diagnosis of infection and severity of disease, prediction of outcome, guidance and success of therapeutic interventions [ 10].

Since then we have had the Nice Improving Outcomes Guidance series and the NHS Cancer Plan for England, which has increased the number of cancer consultants and established specialist multidisciplinary teams," said Duleep Allirajah of Macmillan Cancer Support.

However, National Institute of Clinical Excellence NICEE) clinical outcomes guidance recommends discharge from follow-up at 3 years (National Institute of Clinical Excellence, 2002).

Many individual standards were taken directly from the 'Improving Outcomes' guidance.

The Improving Outcomes Guidance (IOG) series started with breast cancer in 1996.

10 11 This brought substantial financial investment to cancer services together with detailed improving outcomes guidance on individual cancers.

Finally, the Improving Outcomes Guidance recommended that all patients should be discussed by the specialist MDT [ 5].

The Department of Health and National Institute for Health and Clinical Excellence (NICE) have developed a comprehensive package of national guidance (the Improving Outcomes Guidance) for different cancers, including rare tumours.